Similarly, although our preliminary analysis suggests that PSMD12 is negatively correlated with the progression of COAD, cytological experiments show that PSMD12 promotes the growth of breast cancer by inhibiting the expression of pro-apoptotic genes, which is expected to become a potential molecular target for prognosis and treatment (Du et al., 2020). This evidence concerns the gene PSMD12 and breast carcinoma.